DEERFIELD, Ill.--(BUSINESS WIRE)--Apr. 4, 2018--
Baxter International Inc. (NYSE: BAX), will host a conference call to
discuss its first quarter 2018 financial results on Thursday, April 26,
2018, at 7:30 a.m. Central Daylight Time.
To access the call, dial 844-886-1929 (domestic) or 225-239-4663
(international). Please dial into the call at least 10 minutes prior to
the start for the operator to connect you. The Conference ID is 9881128.
This call is also being webcast by Nasdaq OMX and can be accessed at
Baxter’s website at www.baxter.com.
The conference call will be recorded by Baxter and is copyrighted
material. It cannot be recorded or rebroadcast without Baxter’s
Baxter International Inc. provides a broad portfolio of essential
healthcare products across its portfolio, including acute and chronic
dialysis therapies; sterile IV solutions; infusion systems and devices;
parenteral nutrition therapies; inhaled anesthetics; generic injectable
pharmaceuticals; and surgical hemostat and sealant products. The
company’s global footprint and the critical nature of its products and
services play a key role in expanding access to healthcare in emerging
and developed countries. Baxter’s employees worldwide are building upon
the company’s rich heritage of medical breakthroughs to advance the next
generation of healthcare innovations that enable patient care.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180404006238/en/
Source: Baxter International Inc.
Baxter International Inc.